» Articles » PMID: 12676457

Peroxynitrite-induced Cytotoxicity: Mechanism and Opportunities for Intervention

Overview
Journal Toxicol Lett
Publisher Elsevier
Specialty Toxicology
Date 2003 Apr 5
PMID 12676457
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxynitrite is formed in biological systems when superoxide and nitric oxide are produced at near equimolar ratio. Although not a free radical by chemical nature (as it has no unpaired electron), peroxynitrite is a powerful oxidant exhibiting a wide array of tissue damaging effects ranging from lipid peroxidation, inactivation of enzymes and ion channels via protein oxidation and nitration to inhibition of mitochondrial respiration. Low concentrations of peroxynitrite trigger apoptotic death, whereas higher concentrations induce necrosis with cellular energetics (ATP and NAD) serving as switch between the two modes of cell death. Peroxynitrite also damages DNA and thus triggers the activation of DNA repair systems. A DNA nick sensor enzyme, poly(ADP-ribose) polymerase-1 (PARP-1) also becomes activated upon sensing DNA breakage. Activated PARP-1 cleaves NAD(+) into nicotinamide and ADP-ribose and polymerizes the latter on nuclear acceptor proteins. Peroxynitrite-induced overactivation of PARP consumes NAD(+) and consequently ATP culminating in cell dysfunction, apoptosis or necrosis. This cellular suicide mechanism has been implicated among others in the pathomechanism of stroke, myocardial ischemia, diabetes and diabetes-associated cardiovascular dysfunction. Here, we review the cytotoxic effects (apoptosis and necrosis) of peroxynitrite focusing on the role of accelerated ADP-ribose turnover. Regulatory mechanisms of peroxynitrite-induced cytotoxicity such as antioxidant status, calcium signalling, NFkappaB activation, protein phosphorylation, cellular adaptation are also discussed.

Citing Articles

Influence of the agrochemical benomyl on Cryptococcus gattii-plant interaction in vitro and in vivo.

Dornelas J, Paixao V, Carmo P, Costa M, Gomes E, de Resende-Stoianoff M Braz J Microbiol. 2024; 55(3):2463-2471.

PMID: 38963475 PMC: 11405651. DOI: 10.1007/s42770-024-01440-9.


A nanocomposite competent to overcome cascade drug resistance in ovarian cancer mitochondria dysfunction and NO gas synergistic therapy.

Zhong M, Liang P, Feng Z, Yang X, Li G, Sun R Asian J Pharm Sci. 2024; 18(6):100872.

PMID: 38161785 PMC: 10755721. DOI: 10.1016/j.ajps.2023.100872.


RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.

Oronsky B, Takahashi L, Gordon R, Cabrales P, Caroen S, Reid T Front Oncol. 2023; 13:1204143.

PMID: 37313460 PMC: 10258348. DOI: 10.3389/fonc.2023.1204143.


Clarifying the mechanism of apigenin against blood-brain barrier disruption in ischemic stroke using systems pharmacology.

Wang X, Yu Z, Dong F, Li J, Niu P, Ta Q Mol Divers. 2023; 28(2):609-630.

PMID: 36949297 DOI: 10.1007/s11030-023-10607-9.


Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics.

Ramos E, Gil-Martin E, de Los Rios C, Egea J, Lopez-Munoz F, Pita R Antioxidants (Basel). 2023; 12(2).

PMID: 36829956 PMC: 9952307. DOI: 10.3390/antiox12020397.